Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
---|
02/05/1998 | WO1998004698A1 Use of a lestr/fusin/cxcr4 receptor ligand chemokine (sdf-1) for treating or preventing hiv-type viral infection |
02/05/1998 | WO1998004697A1 Cdo tumor suppressor gene and protein |
02/05/1998 | WO1998004694A2 Secreted proteins and polynucleotides encoding them |
02/05/1998 | WO1998004693A2 Secreted proteins and polynucleotides encoding them |
02/05/1998 | WO1998004692A2 Human neuronatin |
02/05/1998 | WO1998004691A1 Human proteolipid |
02/05/1998 | WO1998004690A1 Porcine leptin protein, nucleic acid sequences coding therefor and uses thereof |
02/05/1998 | WO1998004688A1 Egf-like factor from chromaffin granules and glia cell-derived neurotrophic factor with survival-promoting activity on daergic neurons |
02/05/1998 | WO1998004686A2 Pro-protein converting enzyme |
02/05/1998 | WO1998004683A1 Cdo tumor suppressor gene and protein |
02/05/1998 | WO1998004682A1 Adipogenic differentiation of human mesenchymal stem cells |
02/05/1998 | WO1998004592A1 Simplified production of bispecific antibody fragments |
02/05/1998 | WO1998004591A1 Novel parathyroid hormone-related peptide analogs |
02/05/1998 | WO1998004590A1 Conservin compositions and therapeutic and diagnostic uses therefor |
02/05/1998 | WO1998004589A2 Production of recombinant plasma gelsolin containing a disulfide bond |
02/05/1998 | WO1998004585A2 Novel human macrophage antigen |
02/05/1998 | WO1998004584A1 Cyclic decapeptide antibiotics |
02/05/1998 | WO1998004583A1 Conformationally constrained backbone cyclized somatostatin analogs |
02/05/1998 | WO1998004582A1 Isolated peptides derived from mage-2 |
02/05/1998 | WO1998004581A1 Dolastatin pentapeptide derivatives and their use as antitumor agents |
02/05/1998 | WO1998004348A1 Filter sheet and process for purifying photoresist composition employing the filter sheet |
02/05/1998 | WO1998004291A1 2-methoxyestradiol-induced apoptosis in cancer cells |
02/05/1998 | WO1998004290A2 Compositions comprising an inducing agent and an anti-viral agent for the treatment of blood, viral and cellular disorders |
02/05/1998 | WO1998004286A2 Assembly-deficient herpesvirus vaccine |
02/05/1998 | WO1998004283A1 Antiprotozoal composition |
02/05/1998 | WO1998004281A1 Improved method of treating immune cell mediated systemic diseases |
02/05/1998 | WO1998004280A2 Topical composition containing amino acid in combination with either interferon or thymidine derivatives for treating viral or inflammation diseases |
02/05/1998 | WO1998004279A1 Pharmaceutical compositions for the treatment of transplant rejection, autoimmune or inflammatory conditions comprising cyclosporin a and 40-0-(2-hydroxiethyl)-rapamycin |
02/05/1998 | WO1998004278A2 Tetrapeptide derivatives of dolastatin as antitumor agents |
02/05/1998 | WO1998004277A1 Peptidyl prodrugs and methods of making and using the same |
02/05/1998 | WO1998004256A1 Amino acid compositions and use thereof in immunosuppression |
02/05/1998 | WO1998004247A1 Cell adhesion inhibitors |
02/05/1998 | WO1998004245A1 Use of transglutaminase modulators to promote wound healing |
02/05/1998 | WO1997047744A3 T-cell selective interleukin-4 agonists |
02/05/1998 | WO1997044346A3 Specific inhibitors of dna methyltransferase enzyme |
02/05/1998 | WO1997040183A3 Artificial chromosomes, uses thereof and methods for preparing artificial chromosomes |
02/05/1998 | WO1997040151A3 Secreted proteins and polynucleotides encoding them |
02/05/1998 | WO1997040069A3 Secreted proteins and polynucleotides encoding them |
02/05/1998 | WO1997038084A3 Polynucleotides derived from a pbmc cdna library encoding secreted proteins |
02/05/1998 | WO1997033912A3 Uses of gdnf and gdnf receptor |
02/05/1998 | WO1997032991A3 Gene therapy for the treatment of solid tumors using recombinant adeno-associated virus vectors |
02/05/1998 | DE19732918A1 Foodstuff containing hydrolysed feather wholemeal |
02/05/1998 | DE19630896A1 Verwendung eines Gens für humanen vaskulären Endothelzell-Wachstumsfaktor zur direkten Gentherapie Use of a gene for human vascular endothelial growth factor gene therapy for direct |
02/05/1998 | CA2289699A1 Secreted proteins and polynucleotides encoding them |
02/05/1998 | CA2262533A1 2-methoxyestradiol and p53-induced apoptosis in cancer cells |
02/05/1998 | CA2262440A1 Substrate trapping protein tyrosine phosphatases |
02/05/1998 | CA2262412A1 Porcine leptin protein, nucleic acid sequences coding therefor and uses thereof |
02/05/1998 | CA2262013A1 Herpes simplex virus icp4 is an inhibitor of apoptosis |
02/05/1998 | CA2261886A1 Peptidyl prodrugs and methods of making and using the same |
02/05/1998 | CA2261862A1 Filter sheet and process for purifying photoresist composition employing the filter sheet |
02/05/1998 | CA2261581A1 Secreted proteins and polynucleotides encoding them |
02/05/1998 | CA2261575A1 Novel human macrophage antigen |
02/05/1998 | CA2261563A1 Human proteolipid |
02/05/1998 | CA2261071A1 Assembly-deficient herpesvirus vaccine |
02/05/1998 | CA2260956A1 Amino acid compositions and use thereof in immunosuppression |
02/05/1998 | CA2260740A1 A novel human mrna editing enzyme |
02/05/1998 | CA2259948A1 Use of a lestr/fusin/cxcr4 receptor ligand chemokine (sdf-1) for treating or preventing hiv-type viral infection |
02/05/1998 | CA2259924A1 Proteins, in particular membrane proteins, of helicobacter pylori, their preparation and use |
02/05/1998 | CA2232710A1 Medically beneficial preparation for topical use containing amino acids |
02/04/1998 | EP0822260A1 Substance fa-70d, process for producing the same, and uses thereof |
02/04/1998 | EP0822255A2 CHO (Chinese Hamster Ovary) glycosylated antibodies and their use in therapy |
02/04/1998 | EP0822200A1 Synthesis of analogs of PTH and PTrP |
02/04/1998 | EP0822199A2 N-terminally monopegylated polypeptides and process for their preparation. |
02/04/1998 | EP0821969A2 Medicinal Composition comprising TCF-II |
02/04/1998 | EP0821968A2 Antihypertensive agent and method for preparing same |
02/04/1998 | EP0821952A1 Use of isoxazole and crotonic acid amide derivatives for the modulation of apoptosis |
02/04/1998 | EP0821793A1 Methods of screening for therapeutic agents using novel apoptosis-modulating proteins |
02/04/1998 | EP0821740A1 High efficiency ex vivo transduction of hematopoietic stem cells by recombinant retroviral preparations |
02/04/1998 | EP0821739A1 An adenovirus helper-virus system |
02/04/1998 | EP0821736A1 Bacteriocins |
02/04/1998 | EP0821735A1 Helicobacter pylori cagi region |
02/04/1998 | EP0821734A2 Use of an "immunodeficiency-virus suppressing lymphokine (isl)" to inhibit the replication of viruses, in particular of retroviruses |
02/04/1998 | EP0821732A1 Altered polypeptides with increased half-life |
02/04/1998 | EP0821731A1 Modulator of neuronal cell response to inhibition by cns myelin |
02/04/1998 | EP0821730A1 Chimeric receptors for regulating cellular proliferation and effector function |
02/04/1998 | EP0821728A1 Tie-2 ligands, methods of making and uses thereof |
02/04/1998 | EP0821698A1 Protective helicobacter antigens |
02/04/1998 | EP0821697A1 Method for preparing streptogramines |
02/04/1998 | EP0821696A1 Peptide antagonists of cellular mitogenesis and motogenesis and their therapeutic use |
02/04/1998 | EP0821695A1 Antibody purification by low-ph hydrophobic interaction chromatoggraphy |
02/04/1998 | EP0821694A1 Conotoxin peptides |
02/04/1998 | EP0821693A1 Novel human cytomegalovirus dna sequences |
02/04/1998 | EP0821689A1 Tumor protease activated prodrugs of phosphoramide mustard analogs |
02/04/1998 | EP0821670A1 N-aroylamino acid amides as endothelin inhibitors |
02/04/1998 | EP0821592A1 Compositions and methods for regulating hair growth |
02/04/1998 | EP0821591A1 Cns neurite outgrowth modulators, and compositions, cells and methods embodying and using same |
02/04/1998 | EP0821589A1 Compositions and methods to prevent toxicity induced by nonsteroidal antiinflammatory drugs |
02/04/1998 | EP0821583A1 Dna vaccines against rotavirus infections |
02/04/1998 | EP0821551A1 Screening assay for the identification of inhibitors of macrophage migration inhibitory factor |
02/04/1998 | EP0694044A4 Method and product for regulating cell responsiveness to external signals |
02/04/1998 | EP0671933B1 Novel uses of il-10 |
02/04/1998 | EP0651800B1 Basophil granule proteins |
02/04/1998 | EP0568537B1 Genetic modification of endothelial cells |
02/04/1998 | EP0506821B1 Hybrid protein c |
02/04/1998 | EP0460072B1 Human elastase inhibitor |
02/04/1998 | EP0383837B1 Alveolar surfactant proteins |
02/04/1998 | CN1172502A In vivo mutations and polymorphisms in 17 q -linked breast and ovarian cancer susceptibility gene |
02/04/1998 | CN1172486A Proline derivatives useful as inhibitors of human leukocyte elastase |
02/04/1998 | CN1172435A Use of non-mammalian DNA virus to express exogenous gene in mammalian cell |
02/04/1998 | CN1172434A Use of angiotensin II fragments and analogs thereof in tissue repair |